Analysis of visual evoked potentials in patients with neurofibromatosis type 1: new concepts.

P100 latency cognitive disorders neurofibromatosis type 1 optic pathway gliomas visual evoked potentials

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2024
Historique:
received: 31 03 2024
accepted: 11 07 2024
medline: 6 8 2024
pubmed: 6 8 2024
entrez: 6 8 2024
Statut: epublish

Résumé

Neurofibromatosis type 1 (NF type 1) is an autosomal dominant disease with typical clinical manifestations, such as skin lesions, Lisch nodules, optic pathway gliomas, and neurofibromas, caused by the mutation of the NF1 gene. Visual evoked potentials (VEP) present a measure of the electrophysiological response of visual cortex to a visual stimulus. The role of VEP in the pathophysiology of NF type 1 is very complex and requires additional research. We examined the differences between NF type 1 patients with normal and altered VEP and analyzed the correlation between the prolongation of P100 latency and disease severity. Two groups were formed: a control group and a study group with NF type 1 patients. Based on the control group analysis, a threshold value for a normal VEP finding of 116 ms was obtained, and it was used to divide the study group into subgroups with normal and altered VEP. We proceeded with examining the differences in clinical manifestations of the disease between the subgroups, after which we checked if there is a correlation between the prolongation of the P100 latency and the severity of the clinical picture according to the Riccardi scale. Statistical analysis was performed using the Pearson chi-square test and the Spearman correlation test in the program SPSS 28.0, with levels of statistical significance In the group with the abnormal VEP we found a statistically significant more frequent occurrence of optic tract glioma ( Our results showed the important role of VEP in the description of clinical phenotypes of NF type 1. The authors of the study propose VEP to be included in the diagnostic algorithms designed for patients with NF type 1.

Identifiants

pubmed: 39105060
doi: 10.3389/fneur.2024.1410101
pmc: PMC11298334
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1410101

Informations de copyright

Copyright © 2024 Jancic, Zarkovic, Nikolic, Ivancevic, Rovcanin and Nesic.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Jasna Jancic (J)

Clinic of Neurology and Psychiatry for Children and Youth, Belgrade, Serbia.
Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Nikola Zarkovic (N)

Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Blazo Nikolic (B)

Clinic of Neurology and Psychiatry for Children and Youth, Belgrade, Serbia.
Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Nikola Ivancevic (N)

Clinic of Neurology and Psychiatry for Children and Youth, Belgrade, Serbia.
Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Branislav Rovcanin (B)

Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Center for Endocrine Surgery, Clinical Center of Serbia, Belgrade, Serbia.

Dejan Nesic (D)

Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Institute of Medical Physiology, Belgrade, Serbia.

Classifications MeSH